High Court's Abortion Pill Ruling Shuts Out Future Challenges

By Jaime Santos and Annaka Nava ( June 18, 2024, 6:56 PM EDT) -- On June 13, the U.S. Supreme Court issued a unanimous opinion in U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine, holding that anti-abortion doctors and medical associations lack standing to challenge the FDA's decision to relax regulatory requirements related to mifepristone, an abortion drug. The ruling maintains the status quo for mifepristone access, which varies by state....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as